These two have just resigned:
Dr Daryl Rees
Chief Executive Officer
Dr Daryl Rees has a MSc in Pharmacology and a PhD in Clinical Pharmacology. Dr Rees joined Phytopharm in June 1999 from University College London where he was a senior lecturer in Clinical Pharmacology. Prior to this Dr Rees gained 10 years' experience in the discovery and clinical development of medicines as a senior scientist at Wellcome and was part of a multidisciplinary team involved in the discovery of the L-arginine- NO pathway. He is an honorary senior lecturer in the Department of Medicine at University College London, a former editor of the British Journal of Pharmacology and is chairman of Cambridgeshire 1 accredited Research Ethics Committee.
Mr Piers Morgan
Chief Financial Officer
Mr Morgan has an MA in Law and Management Studies from Cambridge University and is a Chartered Accountant. He worked at Close Brothers Corporate Finance on a wide variety of Equity Capital Market and Mergers & Acquisitions transactions and was a founding director of the Life Sciences Mergers & Acquisitions team at Ernst & Young. In 2000, he joined Arrow Therapeutics Limited (acquired by Astra Zeneca for $150m) as Finance Director, raising significant finance through private equity, debt and grants. In 2005, he moved to Paris to become Chief Financial Officer of BioAlliance SA, where he led the successful flotation of the company on Euronext Paris.
No comments:
Post a Comment